CHMP says yes to Esmya for uterine fibroids symptoms and Vepacel pre-pandemic flu vaccine
This article was originally published in Scrip
Executive Summary
The European Medicines Agency's scientific committee, the CHMP, has issued a positive opinion for PregLem France's Esmya (ulipristal acetate), for pre-operative treatment of symptoms of uterine fibroids in adult women, and Baxter's A/H5N1 pre-pandemic flu vaccine, Vepacel.